Clinical Trial Diversity Would Benefit From Regulatory, Financial Incentives, Experts Say

 
• By Sue Sutter
  
Carrot and stick
Regulatory incentives could serve as the 'carrot' to counterbalance the FDA's guidance 'stick.' • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D